Pharma outsourcing recovering, but tough times are ahead
November 26, 2010Manufacturing and Production, Research and Development AAPS, American Association of Pharmaceutical Sciences, Jim Miller, Pharmsource, contract manufacturing, contract research, pharma outsourcing
There are signs that outsourcing in the pharmaceutical sector is staging a comeback after a couple of tough operating years, …
Contract research news in brief
November 26, 2010Research and Development Chemir Analytical Services, Convergence, Cyanta, ICON, Iris Pharma, PRA, Proteome Sciences, Selcia, chiltern, contract research
Our round-up of recent development in the contract research sector includes updates from Selcia, Iris Pharma, ICON, Proteome Sciences, Chiltern, …
Roche’s Sam Ogden joins the ABPI
November 25, 2010Medical Communications, Sales and Marketing ABPI, Sam Ogden, appointment, medical communications, sales and marketing
The ABPI has appointed Sam Ogden as membership engagement account director. She is currently head of in-field effectiveness at Roche …
Europe tightens patient information proposals
November 25, 2010Medical Communications, Sales and Marketing European Commission, European Parliament, dtc, patient information
European restrictions on patient access to medicines information are still on track to be relaxed, but the proposed changes have …
Gilead’s pill shows promise in HIV prevention
November 25, 2010Research and Development, Sales and Marketing AIDS, Bill and Melinda Gates Foundation, Gilead, HIV, UN, UNAIDS, emtricitabine, tenofovir
Gilead’s HIV drug Truvada can help prevent men from contracting the disease through sexual intercourse, a new study shows.The clinical …
UN says Treatment 2.0 approach needed for AIDS
November 25, 2010Research and Development, Sales and Marketing AIDS, HIV, UN, UNAIDS
A new report on the spread of AIDS has called for the development of new pharma compounds that will lead …
Roche set to challenge NICE Tarceva decision
November 25, 2010Sales and Marketing NICE, Roche, Roche UK, Tarceva, erlotinib, lung cancer
NICE has again rejected Roche’s lung cancer drug Tarceva in its second round of draft guidance. Tarceva (erlotinib) was being …
The renal cell carcinoma market: Votrient to challenge Sutent’s lead
November 25, 2010Sales and Marketing GSK, GlaxoSmithKline, Pfizer, Sutent, Votrient, rcc, renal cell carcinoma
After decades of no new medicines emerging to treat renal cell carcinoma, no fewer than five new drugs were approved …
GSK sells antibiotics assets to Dr Reddy’s
November 24, 2010Manufacturing and Production, Sales and Marketing Antibiotics, Dr Reddy's, GSK
Dr. Reddy’s Laboratories has bought a US oral penicillin facility from GSK, along with the US marketing rights to the …
Varnish chemical migrates into medicine bottles, says study
November 24, 2010Manufacturing and Production AAPS, HDPE, chemical migration, varnish
A chemical found in the varnish coating of pharmaceutical bottles has been show to migrate into the contents and be …
Brain cancer vaccine to move into phase III
November 24, 2010Research and Development, Sales and Marketing Celldex, Pfizer, brain cancer, glioblastoma
Celldex will press ahead with large-scale trials of its vaccine treatment for brain cancer after encouraging phase II results. The …
NICE recommends Herceptin for gastric cancer, blocks high dose Glivec
November 24, 2010Sales and Marketing Cancer, GIST, Glivec, HER2, Herceptin, NICE, gastric cancer
NICE has recommended Roche’s cancer drug Herceptin for patients with HER2 metastatic gastric cancer. NICE was initially minded not to …
Healthcare, politics and the NHS
November 24, 2010Research and Development Academy of Medical Sciences, Les Roes, NHS, clinical trials, clinical trials governance, evidence-based medicine
I have just participated in a consultation by the Academy of Medical Sciences on the regulation and governance of clinical …
Pharma manufacturing news in brief
November 23, 2010Manufacturing and Production Alpah Biologics, Alpha Biologics, Kemwell, Lonza, Phil Taylor, Roche
Facility updates from Roche, Alpha Biologics, Kemwell and Reinnervate, new contract services from Lonza and Patheon, plus a milestone in …
Brinsmead to be life sciences adviser to government
November 23, 2010Sales and Marketing Brinsmead, NHS, government, life sciences
Chris Brinsmead, chairman of AstraZeneca UK, has been made the government’s life sciences business adviser. He was appointed by universities …
Roche to develop diagnostic tools for Tarceva
November 23, 2010Sales and Marketing Genzyme, NSCLC, Roche, Tarceva, diagnostic
Roche has obtained a worldwide sub-license from Genzyme to develop a diagnostic kit for the detection of specific mutations for …
Vytorin cuts heart problems in kidney patients
November 23, 2010Sales and Marketing Merck, Vytorin, cardiovascular, simvastatin
Vytorin has been shown to reduce potentially heart problems in patients with chronic kidney disease (CKD) in a new study. …
Offshore outsourcing in Regulatory Affairs and Pharmacovigilance
November 22, 2010Sales and Marketing Kinapse, White paper
Based on Kinapse’s direct experience, we explore the emerging environment for regulatory and pharmacovigilance offshore outsourcing within the biopharmaceutical industry …
A new generation of analogues for valuing strategy
November 22, 2010Sales and Marketing Alex Blyth, MSI, forecasting, marketing, marketing strategy
Anyone who is involved in the planning of pharma marketing campaigns will know that the Holy Grail is trying to …
Chris King joins Synovate Healthcare
November 22, 2010Sales and Marketing Chris King, Synovate Healthcare, appointment, sales and marketing
Synovate has appointed Chris King head of its European Oncology Monitor within its specialist healthcare research division. He joins the …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
